Dietary interventions for multiple sclerosis (Q24202428)

4

0 references

Laura Vacchi

object named as

Laura Vacchi

2

0 references

author name string

Mariangela Farinotti

1

0 references

Silvana Simi

3

0 references

Lorenzo Brait

Cochrane Database of Systematic Reviews

5

0 references

language of work or name

English

0 references

publication date

12 December 2012

0 references

published in

0 references

volume

12

0 references

page(s)

CD004192

0 references

cites work

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Double-blind Trial of Linoleate Supplementation of the Diet in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Alfacalcidol treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Polyunsaturated fatty acids and colchicine in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Treatment and management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Letter: Linoleic acid in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Neuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Effect of low saturated fat diet in early and late cases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Review of MS patient survival on a Swank low saturated fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Lipoic acid in multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Diet and the geographical distribution of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Current Complementary and Alternative Therapies for Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Environmental risk factors in MS: a case-control study in Moscow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Nutrition in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Vitamin D for the management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Small-bowel abnormalities in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

The food pattern in geographical relation to the risk of multiple sclerosis in the Mediterranean and Near East region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Diet and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Vitamin B12, demyelination, remyelination and repair in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Multiple sclerosis--one manifestation of neurobrucellosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Examining the evidence: complementary adjunctive therapies for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Multiple sclerosis, latitude and dietary fat: is pork the missing link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Nutrition and diet in the clinical management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Vitamin B12, folic acid, and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

The molecular basis of nutritional intervention in multiple sclerosis: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Multiple sclerosis and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Complementary and alternative medicine for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Risk factors of multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

Multiple Sclerosis: Twenty Years on Low Fat Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Multiple sclerosis and nutrition

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Double-blind Trial of Linoleic Acid in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Vitamin B12 metabolism in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Treatment of multiple sclerosis with low-fat diet

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Treatment of multiple sclerosis with low-fat diet; results of five and one-half years' experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety, and absorption of selenium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Prevention of corticosteroid-induced osteoporosis by alfacalcidol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Patterns of dietary and herbal supplement use by multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Long-term treatment of multiple sclerosis with corticotrophin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Effect of gamma-linolenate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Is there a role for saturated and long-chain fatty acids in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

How saturated fats may be a causative factor in multiple sclerosis and other diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Lipids and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Complementary and Alternative Medicine in Multiple Sclerosis: Survey of Licensed Naturopaths

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Multiple sclerosis: the lipid relationship

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

The influence of low-fat diet on blood lipid levels in health and in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Multiple sclerosis and macrocytosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Trail of polyunsaturated fatty acids in non-relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Efficacy of cranberry juice and ascorbic acid in acidifying the urine in multiple sclerosis subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

MULTIPLE SCLEROSIS AND GEOGRAPHY. NEW INTERPRETATION OF EPIDEMIOLOGICAL OBSERVATIONS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Role of food allergy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Utilization of unconventional treatments by persons with MS: is it alternative or complementary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

Treatment of multiple sclerosis with low-fat diet: result of seven years' experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004192.PUB3

7 January 2021

10.1002/14651858.CD004192.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_uqobk6y46bdrtj3feqw2dvxwym

2885222

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uqobk6y46bdrtj3feqw2dvxwym

24 November 2022

mapped directly with Wikidata item

2885222

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference